StockData

Intercure Ltd. (INCR) stock

INCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 30, 2026Score 3/30
$3.49−0.12 (-3.31%)

Close on Nov 18, 2026Market cap $190.84MP/E –Yield –

Intercure operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

For fiscal 2025 it was 16.84M ILS. The highest annual figure on record is 51.27M ILS in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 202516.84M ILS–
FY2024Dec 31, 2024-66.93M ILS–
FY2023Dec 31, 2023-53.63M ILS-204.6%
FY2022Dec 31, 202251.27M ILS+70.1%
FY2021Dec 31, 202130.14M ILS+281.6%
FY2020Dec 31, 20207.90M ILS–
FY2019Dec 31, 2019-11.57M ILS–

More Intercure figures

See a number that looks wrong?